ARTHROCARE 8000S COBLATOR SURGERY SYSTEM

K053297 · Arthrocare Corp. · GEI · Dec 6, 2005 · General, Plastic Surgery

Device Facts

• Record ID: K053297
• Device Name: ARTHROCARE 8000S COBLATOR SURGERY SYSTEM
• Applicant: Arthrocare Corp.
• Product Code: GEI · General, Plastic Surgery
• Decision Date: Dec 6, 2005
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 878.4400
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The ArthroCare 8000S Coblator Surgery System is indicated for ablation, resection, and coagulation of soft tissue and hemostasis of blood vessels in orthopedic, arthroscopic, spinal, and neurological procedures.

Device Story

Bipolar, high-frequency electrosurgical system; consists of Controller (generator), disposable bipolar Wands, and reusable Patient Cable. Used in OR for orthopedic, arthroscopic, spinal, and neurological procedures. Operated by surgeons. Device delivers high-frequency energy to Wands to perform soft tissue ablation, resection, coagulation, and hemostasis. Output allows precise tissue management; benefits patient through controlled surgical intervention.

Clinical Evidence

No clinical data provided; substantial equivalence based on design and performance specification modifications.

Technological Characteristics

Bipolar electrosurgical system; includes generator (Controller), disposable bipolar Wands, and reusable Patient Cable. High-frequency energy source. System is a modification of predicate K001588 involving performance and dimensional specifications.

Indications for Use

Indicated for soft tissue ablation, resection, coagulation, and hemostasis in orthopedic, arthroscopic, spinal, and neurological procedures. No specific patient age or gender restrictions provided.

Regulatory Classification

Identification

An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current.

Predicate Devices

• ArthroCare® System 2000 (K001588)

Submission Summary (Full Text)

{0}------------------------------------------------

Page 1 of 2

## KO53297 ArthroCare Corporation ArthroCare 8000S Coblator Surgery System

510(k) Summary

#### General Information

| Submitter Name/Address: | ArthroCare Corporation<br>680 Vaqueros Avenue<br>Sunnyvale, CA 94085-2936 |
|-------------------------|---------------------------------------------------------------------------|
| Phone Number: | [phone] |
| Contact Person: | Valerie Defiesta-Ng<br>Director, Regulatory Affairs |
| Date Prepared: | November 23, 2005 |

**Device Description**

| Trade Name: | ArthroCare 8000S Coblator Surgery System |
|----------------------|----------------------------------------------------------------------------------|
| Generic/Common Name: | Electrosurgical Device and Accessories |
| Classification Name: | Electrosurgical Cutting and Coagulation Device and Accessories (21 CFR 878.4400) |

**Predicate Devices**

| ArthroCare® System 2000 | K001588 |
|-------------------------|---------|
|-------------------------|---------|

#### Product Description

The ArthroCare 8000S Coblator Surgery System is a bipolar, high frequency electrosurgical system consisting of three components: an electrosurgical generator called the Controller; a family of disposable, bipolar, single use Wands; and a reusable Patient Cable.

#### Intended Uses

The ArthroCare 8000S Coblator Surgery System is indicated for ablation, resection, and coagulation of soft tissue and hemostasis of blood vessels in orthopedic, arthroscopic, spinal, and neurological procedures.

{1}------------------------------------------------

K053297

Page 2 of (2)

#### Substantial Equivalence

This Special 510(k) proposes a modification in the performance specifications, dimensional specifications, and labeling for the ArthroCare System 2000, which was onnensional specificanent in K001588 on August 17, 2000. The indications for use, tcchnology, provide of operation, materials, packaging, and sterilization parameters of the ArthroCarc 8000S Coblator Surgery System remain the same as in the predicate cleared 510(k).

### Summary of Safety and Effectiveness

The ArthroCare 8000S Coblator Surgery System, as described in this Special 510(k), is substantially equivalent to the predicate device. The proposed modifications in performance specifications, dimensional specifications, and labeling are not substantial changes or modifications, and do not significantly affect the safety or efficacy of the System.

{2}------------------------------------------------

Image /page/2/Picture/1 description: The image is a black and white seal for the Department of Health and Human Services, USA. The seal is circular and contains the words "DEPARTMENT OF HEALTH AND HUMAN SERVICES, USA" around the perimeter. In the center of the seal is a stylized image of three human profiles facing to the right. The profiles are stacked on top of each other, with the top profile being the largest and the bottom profile being the smallest.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

#### DEC 6 2005

Valerie Defiesta-Ng Director, Regulatory Affairs ArthroCare Corporation 680 Vaqueros Avenue Sunnyvale, California 94085-2936

Re: K053297

Trade/Device Name: ArthroCare 8000S Coblator Surgery System Regulation Number: 21 CFR 878.4400 Regulation Name: Electrosurgical cutting and coagulation device and accessories Regulatory Class: II Product Code: GEI, GXI Dated: November 23, 2005 Received: November 25, 2005

Dear Ms. Deficsta-Ng:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{3}------------------------------------------------

Page 2- Valerie Defiesta-Ng

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Barbara BuckMD
for

Mark N. Melkerson Acting Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

# Indications for Use Statement

510(k) Number: K 553297

ArthroCare 8000S Coblator Surgery System Device Name:

Indications for Use:

The ArthroCare 8000S Coblator Surgery System is intended for resection, ablation, and coagulation of soft tissue and hemostasis of blood vessels in orthopedic, arthroscopic, spinal, and neurological procedures.

Prescription Use (21 CFR 801 Subpart D)

OR

Over-the-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)

Clarka v. Buelind for mtn

Division of General, Restorative, and Neurological Devices

X

**510(k) Number** K053297